Accuray Incorporated (ARAY) Q3 2024 Earnings Report

- Accuray reported Q3 FY2024 revenue of $101.1 million, down 14% year over year and 5.7% quarter over quarter, as the company faced a slower U.S. capital equipment environment and timing delays that shifted three system shipments into Q4. Gross margin was 28.7% for the quarter, down from 32.8% a year earlier, with 4.5 percentage points of margin headwinds primarily from a China margin deferral (3.2 points) and foreign exchange impact (1.3 points). Net income was -$6.342 million with an EPS of -$0.0639, while adjusted EBITDA totaled $1.1 million, down from $8.3 million a year ago, pressured by lower revenue and timing effects from JV-related margin deferral.
- The company delivered meaningful topline and backlog indicators despite near-term headwinds: orders grew 21% in Q3 (8% on a trailing-12-month basis), and the book-to-bill ratio stood at 1.8 for the quarter. Installed base rose 4% YoY, with service contract revenue up 2% YoY and 4% on a trailing-12-month basis, signaling durable recurring revenue potential as external conditions improve. Product backlog ended at roughly $503 million, up 2% sequentially and down 1% YoY, with no order cancellations in the quarter.
- Management emphasized a constructive longer-term growth trajectory anchored by regulatory progress and geographic diversification: China Tomo C-related approvals (final Precision Treatment Planning System clearance) are expected to unlock deferred margin and accelerate China revenue growth; EIMEA and APAC regions posted healthier momentum, and Japan remains a profitable but FX-pressured market. The company reaffirmed its multi-year goals of 4-6% revenue CAGR and doubling adjusted EBITDA by FY2026, while acknowledging near-term U.S. budget pressures and timing-related revenue recognition. Guidance for FY24 was updated to $432–$437 million in revenue and $19–$22 million of adjusted EBITDA.
- Investors should weigh the near-term softness in the U.S. with the potential for accelerated revenue and margin expansion as Tomo C (China) clears, Helix launches in India, and service-related margins continue to improve through a growing installed base and higher contract pricing. The balance sheet remains cash-light with net debt of approximately $145.9 million and a cash balance of about $61.1 million at quarter-end, signaling ongoing focus on working capital discipline and cost optimization while funding aggressive growth initiatives.